Activest Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.76K Hold
4,001
﹤0.01% 717
2026
Q1
$6.76K Hold
4,001
﹤0.01% 765
2025
Q4
$7.92K Hold
4,001
﹤0.01% 704
2025
Q3
$11.6K Hold
4,001
﹤0.01% 471
2025
Q2
$7.24K Hold
4,001
﹤0.01% 495
2025
Q1
$6K Hold
4,001
﹤0.01% 483
2024
Q4
$9.44K Hold
4,001
﹤0.01% 324
2024
Q3
$118K Hold
4,001
0.04% 110
2024
Q2
$49.4K Buy
+4,001
New +$84.3K 0.02% 169

Other funds holding FLNA

Activest Wealth Management's FLNA Position: Q2 2026 in Review

Activest Wealth Management held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 4,001 shares worth $4.76K. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Activest Wealth Management first reported a position in FLNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $118K in Q3 2024. 14 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Activest Wealth Management held 4,001 shares of Filana Therapeutics worth $4.76K as of Q2 2026.
  • Activest Wealth Management left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #717 holding.
  • Activest Wealth Management first reported a position in Filana Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Filana Therapeutics position peaked at $118K in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.